This article was originally published in The Gray Sheet
AngioDynamics appoints president and CEO; MDMA announces new VP and general counsel; Wright Medical chief operating officer resigns; and more personnel news from around the industry.
You may also be interested in...
Ivenix names Stuart Randle CEO, as IsoRay Chairman and CEO Dwight Babcock retires; EnteroMedics' new CEO Dan W. Gladney restructures head office; Sunshine Heart names new clinical affairs chief; and more personnel news from around the industry.
Shionogi is hoping to demonstrate the efficacy of its oral COVID-19 candidate Xocova through an appropriate primary endpoint in its Phase III trial, while the Japanese firm is also eyeing global expansion for the drug should a world-first domestic approval be granted.
Beiersdorf Is Having Record Year For Sun Care, Seeing China Recovery, But Full-Year Outlook Is Guarded
The Hamburg, Germany-based firm defied economic and political headwinds and China troubles in the fiscal 2022 first half to book organic net sales growth of 10.5% to €4.5bn worldwide. Despite optimism about China recovery, sun care, and its recent Chantecaille acquisition, Beiersdorf is projecting a slowdown in the second half in what remains a volatile operating environment.